Al-Awadi reviews biological treatments regulations
The Minister of Health, Dr. Ahmed Al-Awadi, issued a ministerial decision to regulate the prescribing, dispensing, and monitoring of biological treatments within the Ministry of Health. The aim is to establish a comprehensive regulatory framework that enhances patient safety and strengthens governance and drug safety. The decision focuses on regulating all stages of biological therapy, from prescribing and dispensing to monitoring clinical and economic outcomes, with the implementation of controls for patient selection and the approval of treatment protocols to ensure the delivery of appropriate therapy at the right time. It also aligns with the development of future treatments, including gene and cell therapies such as CAR-T, with the goal of rationalizing use, achieving efficiency and sustainability, and improving patient safety by tracking side effects and managing biosimilar alternatives.
Notice: This Is an AI-Generated Summary
Comments (0)